Suchergebnisse
UB Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Gefunden in
Art der Quelle
Schlagwort
- cancer -- care and treatment 85 Treffer
- biological products industry 77 Treffer
- immunotherapy 72 Treffer
- cel-sci corp. 71 Treffer
- product development 53 Treffer
-
45 weitere Werte:
- biological products industry -- product development 52 Treffer
- clinical trials 48 Treffer
- cel-sci corp. -- product development 44 Treffer
- cancer 35 Treffer
- business, international 26 Treffer
- drug therapy 24 Treffer
- health 21 Treffer
- head and neck cancer 20 Treffer
- pharmaceutical industry -- product development 16 Treffer
- business 15 Treffer
- stockholders 15 Treffer
- cancer -- drug therapy 13 Treffer
- cancer research 13 Treffer
- general interest 10 Treffer
- media executives 10 Treffer
- web sites (world wide web) 10 Treffer
- biological products industry -- intellectual property 9 Treffer
- intellectual property 9 Treffer
- medical research 9 Treffer
- medicine, experimental 9 Treffer
- oncology, experimental 9 Treffer
- patent/copyright issue 9 Treffer
- patents 9 Treffer
- antimitotic agents 8 Treffer
- antineoplastic agents 8 Treffer
- head and neck cancer -- drug therapy 8 Treffer
- teva pharmaceutical industries ltd. -- product development 8 Treffer
- cel-sci corp. -- intellectual property 6 Treffer
- chief executive officers 6 Treffer
- public relations firms 6 Treffer
- banking, finance and accounting industries 5 Treffer
- care and treatment 5 Treffer
- united states. food and drug administration 5 Treffer
- cancer -- care and treatment -- research 4 Treffer
- immune system 4 Treffer
- interleukins 4 Treffer
- biological products industry -- licensing agreements 3 Treffer
- cancer -- care and treatment -- drug therapy 3 Treffer
- chemotherapy 3 Treffer
- cholesterol 3 Treffer
- company licensing agreement 3 Treffer
- disease susceptibility 3 Treffer
- licensing agreements 3 Treffer
- news, opinion and commentary 3 Treffer
- pharmaceutical industry -- licensing agreements 3 Treffer
Verlag
Publikation
- business wire 59 Treffer
- contify life science news 15 Treffer
- india pharma news 12 Treffer
- accesswire 10 Treffer
- m2 communications 7 Treffer
-
20 weitere Werte:
- midnighttrader live briefs 6 Treffer
- journal of india 5 Treffer
- plus company updates 4 Treffer
- daily the pak banker (lahore, pakistan) 3 Treffer
- plus news 3 Treffer
- globes (tel aviv, israel) 2 Treffer
- m2 equitybites (eqb) 2 Treffer
- m2 presswire 2 Treffer
- marketwired 2 Treffer
- plus financial reports 2 Treffer
- thomson reuters one 2 Treffer
- us official news 2 Treffer
- aids vaccine week 1 Treffer
- aids weekly 1 Treffer
- benzinga.com 1 Treffer
- biotech week 1 Treffer
- cancer vaccine week 1 Treffer
- immunotherapy weekly 1 Treffer
- right vision news 1 Treffer
- rtt news 1 Treffer
Sprache
146 Treffer
-
-
Amgen Phase III Immunotherapy Trials Fail; CVM Last Player On Deck This Year (AMGN, TEVA, DNDN, CVM)In: Benzinga.com, 2010-08-16ZeitungsartikelZugriff:
-
In: M2 Presswire, 2011-04-11ZeitungsartikelZugriff:
-
In: M2 Communications, 2011-04-11ZeitungsartikelZugriff:
-
In: M2 Presswire, 2010-05-05ZeitungsartikelZugriff:
-
In: M2 Communications, 2010-05-05ZeitungsartikelZugriff:
-
OTCMarketBulls: OTCMarketbulls.com Brings You the HOTTEST gainers! Sign Up Today!! RZ, BPZ, CVM, MSOIn: M2 Communications, 2010-02-17ZeitungsartikelZugriff:
-
In: Business Wire, 2024-03-06ZeitungsartikelZugriff:
-
In: Plus Company Updates, 2022-09-08ZeitungsartikelZugriff:
-
In: Business Wire, 2022-04-22ZeitungsartikelZugriff:
-
In: Contify Life Science News, 2021-01-04ZeitungsartikelZugriff:
-
In: Business Wire, 2021-01-04ZeitungsartikelZugriff:
-
In: Plus Company Updates, 2020-12-15ZeitungsartikelZugriff:
-
In: Contify Life Science News, 2020-12-14ZeitungsartikelZugriff:
-
In: Business Wire, 2020-12-14ZeitungsartikelZugriff:
-
In: Plus Company Updates, 2020-09-16ZeitungsartikelZugriff:
-
In: Contify Life Science News, 2020-09-15ZeitungsartikelZugriff:
-
In: Contify Life Science News, 2020-09-11ZeitungsartikelZugriff:
-
In: Business Wire, 2020-09-11ZeitungsartikelZugriff: